Journal
EXPERT REVIEW OF CARDIOVASCULAR THERAPY
Volume 11, Issue 12, Pages 1701-1711Publisher
TAYLOR & FRANCIS INC
DOI: 10.1586/14779072.2013.854165
Keywords
bioartificial myocardium; biohybrid scaffolds; bionanomaterials; cardiac bioregeneration; cardiomyoplasty; cell transplantation; heart failure; myocardial infarction; myocardial regeneration; tissue engineering
Categories
Funding
- European Commission
Ask authors/readers for more resources
The association of stem cells with tissue-engineered scaffolds constitutes an attractive approach for the repair of myocardial tissue with positive effects to avoid ventricular chamber dilatation, which changes from a natural elliptical to spherical shape in heart failure patients. Biohybrid scaffolds using nanomaterials combined with stem cells emerge as new therapeutic tool for the creation of 'bioartificial myocardium' and 'cardiac wrap bioprostheses' for myocardial regeneration and ventricular support. Biohybrids are created introducing stem cells and self-assembling peptide nanofibers inside a porous elastomeric membrane, forming cell niches. Our studies lead to the creation of semi-degradable 'ventricular support bioprostheses' for adaptative LV and/or RV wrapping, designed with the concept of 'helical myocardial bands'. The goal is to restore LV elliptical shape, and contribute to systolic contraction and diastolic filling (suction mechanism). Cardiac wrapping with ventricular bioprostheses may reduce the risk of heart failure progression and the indication for heart transplantation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available